As obesity rates rise in the U.S. and worldwide, new weight-loss drugs surge in popularity
Last year, Ozempic, Rybelsus and Wegovy had combined sales of about $21.1 billion globally – up 89% since 2022.
Numbers, Facts and Trends Shaping Your World
Last year, Ozempic, Rybelsus and Wegovy had combined sales of about $21.1 billion globally – up 89% since 2022.
Just 20% of the public views the coronavirus as a major threat to the health of the U.S. population and only 10% are very concerned about getting a serious case themselves. In addition, a relatively small share of U.S. adults (28%) say they’ve received an updated COVID-19 vaccine since last fall.
Just 12% of Republicans and Republican leaners say dealing with climate change should be a top priority for the president and Congress.
About three-quarters of Americans say they have heard a lot or a little about Ozempic, Wegovy and other similar drugs that are being used for weight loss. Among those familiar with these drugs, 53% think they are good options to lose weight for people with obesity or a weight-related health condition.
More than half of U.S. adults (56%) said that widespread use of brain chips to enhance cognitive function would be a bad idea for society.
More Black Americans say health outcomes for Black people in the United States have improved over the past 20 years than say outcomes have worsened.
The share of Americans who say science has had a mostly positive impact on society has fallen 16 percentage points since before the start of the coronavirus outbreak, from 73% in January 2019 to 57% today.
Seven-in-ten Hispanic Americans say they’ve seen a doctor or other health care provider in the past year, compared with 82% among Americans overall.
A majority of Americans believe climate change is causing harm to people in the U.S. today and 63% expect things to get worse in their lifetime.
The share of Americans who say climate scientists understand very well whether climate change is occurring decreased from 37% in 2021 to 32% this year.